Format

Send to

Choose Destination
Swiss Med Wkly. 2011 May 3;141:w13192. doi: 10.4414/smw.2011.13192. eCollection 2011.

Vitamin D levels in Swiss multiple sclerosis patients.

Author information

1
Department of Neurology, Multiple Sclerosis Outpatient Clinic, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9000 St. Gallen, Szitzerland. yildizmur@yahoo.com

Abstract

BACKGROUND:

Vitamin D levels have not been previously published for Swiss multiple sclerosis (MS) patients. An association between vitamin D status and disease activity in MS has been suggested.

AIM:

To define 25-hydroxy-vitamin D (25(OH)D) levels in Swiss multiple sclerosis patients.

METHOD:

Cross sectional case control study.

RESULTS:

25(OH)D levels of 80 patients (76.3% female, mean age 37.9 ± 10.6 years, mean Expanded Disability Status Scale (EDSS) 2.6 ± 1.2) were collected. Mean levels of 25(OH)D were 57.0 ± 29.7 nmol/l (range 18-175 nmol/l) in all patients. A total of 21.3% of patients had levels ≤37 nmol/l and 75% had levels ≤70 nmol/l. 25(OH)D levels in patients with previous high disease activity were 52.8 ± 23.1 nmol/l versus 58.9 ± 32.3 nmol/l in the low disease activity group (p = 0.4).

CONCLUSION:

The prevalence of 25(OH)D deficiency was high in Swiss MS patients.

PMID:
21541856
DOI:
10.4414/smw.2011.13192
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for EMH Swiss Medical Publishers Ltd.
Loading ...
Support Center